Cart
sales@molnova.com
1-Ethoxycarbonyl-beta-carbolinecarboline
CAS No. 72755-19-2
1-Ethoxycarbonyl-beta-carbolinecarboline( ——— )
Catalog No. M39348 CAS No. 72755-19-2
1-Ethoxycarbonyl-beta-carbolinecarboline
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 360 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-Ethoxycarbonyl-beta-carbolinecarboline
-
NoteResearch use only, not for human use.
-
Brief Description1-Ethoxycarbonyl-beta-carbolinecarboline
-
Description1-Ethoxycarbonyl-beta-carbolinecarboline
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number72755-19-2
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2-(2-bromophenyl)-5-...
2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one is an human neutrophil elastase inhibitor.
-
Lumiliximab
Lumiliximab (IDEC-152) is a primate-ized chimeric antibody targeting CD23 rhesus monkey/human chimeric antibody with inhibitory effects on IgE antibody production for the study of allergic diseases.
-
BRD0639
BRD0639 is a pioneering inhibitor targeting the interaction between PRMT5 and its substrate adaptor.
